Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
Authors
Keywords
Epstein-Barr virus, Phage display, Cancer detection and diagnosis, Binding analysis, Cell fusion, Nasopharyngeal carcinoma, Cell staining, Cytotoxicity
Journal
PLoS Pathogens
Volume 16, Issue 1, Pages e1008223
Publisher
Public Library of Science (PLoS)
Online
2020-01-07
DOI
10.1371/journal.ppat.1008223
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Evaluation of [68Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors
- (2018) Maryam Oroujeni et al. Cells
- Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells
- (2017) John S. Schardt et al. MOLECULAR PHARMACEUTICS
- Affibody Molecules in Biotechnological and Medical Applications
- (2017) Stefan Ståhl et al. TRENDS IN BIOTECHNOLOGY
- Immunogenicity of therapeutic recombinant immunotoxins
- (2016) Ronit Mazor et al. IMMUNOLOGICAL REVIEWS
- Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator
- (2016) Ken G. Andersson et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
- (2016) Jens Sörensen et al. Theranostics
- Preclinical PET imaging of EGFR levels: pairing a targeting with a non-targeting Sel-tagged Affibody-based tracer to estimate the specific uptake
- (2016) Qing Cheng et al. EJNMMI Research
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Affibody-mediated PET imaging of HER3 expression in malignant tumours
- (2015) Maria Rosestedt et al. Scientific Reports
- To Be or Not IIb: A Multi-Step Process for Epstein-Barr Virus Latency Establishment and Consequences for B Cell Tumorigenesis
- (2015) Alexander M. Price et al. PLoS Pathogens
- TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation
- (2015) Hannah Greenfeld et al. PLoS Pathogens
- Pseudomonas Exotoxin A: optimized by evolution for effective killing
- (2015) Marta Michalska et al. Frontiers in Microbiology
- Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
- (2014) Bogdan Mitran et al. AMINO ACIDS
- First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
- (2014) J. Sorensen et al. JOURNAL OF NUCLEAR MEDICINE
- The role of Epstein-Barr virus in epithelial malignancies
- (2014) Sai-Wah Tsao et al. JOURNAL OF PATHOLOGY
- Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
- (2013) Whay-Kuang Chia et al. MOLECULAR THERAPY
- Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
- (2013) Magdalena Malm et al. PLoS One
- Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis
- (2013) Ming-Yuan Chen et al. Chinese Journal of Cancer
- Cellular Effects of HER3-Specific Affibody Molecules
- (2012) Lovisa Göstring et al. PLoS One
- The Development of Peptide-Based Tools for the Analysis of Angiogenesis
- (2011) Anna Fedorova et al. CHEMISTRY & BIOLOGY
- HER2-Affitoxin: A Potent Therapeutic Agent for the Treatment of HER2-Overexpressing Tumors
- (2011) R. Zielinski et al. CLINICAL CANCER RESEARCH
- Canonical NF- B Activation Is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation
- (2011) B. E. Gewurz et al. JOURNAL OF VIROLOGY
- Identification and Characterization of Novel B-Cell Epitopes Within EBV Latent Membrane Protein 2 (LMP2)
- (2011) Xiangyang Xue et al. VIRAL IMMUNOLOGY
- Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
- (2010) J. Löfblom et al. FEBS LETTERS
- Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules
- (2010) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- Affitoxin—A Novel Recombinant, HER2-specific, Anticancer Agent for Targeted Therapy of HER2-positive Tumors
- (2009) Rafal Zielinski et al. JOURNAL OF IMMUNOTHERAPY
- Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line
- (2008) Lina Ekerljung et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now